JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2101
Comtech Telecommunications
CMTL
$37.5M
| $11.1M | ﹤0.01% |
889,203
+16,543
| +2% | +$237K |
2013 Q2
39 quarters
|
|
2102
STAAR Surgical
STAA
$1.13B
| $11.1M | ﹤0.01% |
172,868
+21,405
| +14% | +$1.4M |
2017 Q4
21 quarters
|
|
2103
CALL
Plug Power
PLUG
$2.64B
| $11M | ﹤0.01% |
+940,700
| New | +$13.5M |
2023 Q1
0 quarters
|
|
2104
Trex
TREX
$4.5B
| $11M | ﹤0.01% |
226,212
+31,513
| +16% | +$1.59M |
2013 Q2
39 quarters
|
|
2105
New Fortress Energy
NFE
$33.5M
| $11M | ﹤0.01% |
7,471
+6,994
| +1,466% | +$12.3M |
2021 Q4
5 quarters
|
|
2106
Liberty Global Class C
LBTYK
$3B
| $11M | ﹤0.01% |
538,925
+33,838
| +7% | +$713K |
2013 Q2
39 quarters
|
|
2107
PUT
Norfolk Southern
NSC
$71B
| $11M | ﹤0.01% |
51,800
+41,200
| +389% | +$9.53M |
2021 Q1
8 quarters
|
|
2108
Vaxcyte
PCVX
$11B
| $11M | ﹤0.01% |
292,896
+39,964
| +16% | +$1.7M |
2020 Q3
10 quarters
|
|
|
DX
2109
Dynex Capital
DX
$2.69B
| $11M | ﹤0.01% |
905,243
-595,026
| -40% | -$7.95M |
2016 Q4
25 quarters
|
|
|
ZUO
2110
DELISTED
Zuora, Inc.
ZUO
| $11M | ﹤0.01% |
1,109,364
-98,456
| -8% | -$825K |
2018 Q2
19 quarters
|
|
2111
WSFS Financial
WSFS
$3.95B
| $11M | ﹤0.01% |
291,259
+8,468
| +3% | +$389K |
2013 Q2
39 quarters
|
|
|
PCGU
2112
DELISTED
PG&E Corporation
PCGU
| $10.9M | ﹤0.01% |
76,693
-23,307
| -23% | -$3.24M |
2020 Q3
10 quarters
|
|
2113
Resideo Technologies
REZI
$2.82B
| $10.9M | ﹤0.01% |
596,581
+4,523
| +0.8% | +$81.8K |
2018 Q4
17 quarters
|
|
|
RXDX
2114
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $10.9M | ﹤0.01% |
101,586
-25,489
| -20% | -$2.93M |
2021 Q2
7 quarters
|
|
2115
WIX.com
WIX
$3.1B
| $10.9M | ﹤0.01% |
109,142
+58,254
| +114% | +$5.12M |
2015 Q1
32 quarters
|
|
2116
Uranium Energy
UEC
$4.63B
| $10.9M | ﹤0.01% |
3,781,023
+2,523,430
| +201% | +$9.13M |
2016 Q1
28 quarters
|
|
|
NUVL
2117
DELISTED
Nuvalent
NUVL
| $10.9M | ﹤0.01% |
417,204
-9,222
| -2% | -$273K |
2021 Q3
6 quarters
|
|
2118
Gray Television
GTN
$477M
| $10.9M | ﹤0.01% |
1,247,711
+191,800
| +18% | +$2.14M |
2015 Q2
31 quarters
|
|
2119
Sanmina
SANM
$12.1B
| $10.9M | ﹤0.01% |
178,351
+70,634
| +66% | +$4.23M |
2013 Q2
39 quarters
|
|
2120
Monro
MNRO
$426M
| $10.9M | ﹤0.01% |
219,844
+55,122
| +33% | +$2.74M |
2015 Q4
29 quarters
|
|
2121
TTEC Holdings
TTEC
$68M
| $10.9M | ﹤0.01% |
291,602
+57,783
| +25% | +$2.59M |
2015 Q4
29 quarters
|
|
2122
iShares Morningstar Growth ETF
ILCG
$3.28B
| $10.8M | ﹤0.01% |
195,981
-13,769
| -7% | -$721K |
2013 Q2
39 quarters
|
|
2123
ScottsMiracle-Gro
SMG
$2.86B
| $10.8M | ﹤0.01% |
155,425
+21,653
| +16% | +$1.56M |
2013 Q2
39 quarters
|
|
2124
MaxLinear
MXL
$9.57B
| $10.8M | ﹤0.01% |
307,493
+101,303
| +49% | +$3.67M |
2016 Q2
27 quarters
|
|
2125
InMode
INMD
$813M
| $10.8M | ﹤0.01% |
338,588
+88,745
| +36% | +$3.04M |
2019 Q4
13 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.